72 related articles for article (PubMed ID: 16807671)
1. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
2. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.
Hartkopf AD; Taran FA; Wallwiener M; Hagenbeck C; Melcher C; Krawczyk N; Hahn M; Wallwiener D; Fehm T
Breast Cancer Res; 2013; 15(5):R94. PubMed ID: 24099325
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Magbanua MJM; van 't Veer L; Clark AS; Chien AJ; Boughey JC; Han HS; Wallace A; Beckwith H; Liu MC; Yau C; Wileyto EP; Ordonez A; Solanki TI; Hsiao F; Lee JC; Basu A; Brown Swigart L; Perlmutter J; Delson AL; Bayne L; Deluca S; Yee SS; Carpenter EL; Esserman LJ; Park JW; Chodosh LA; DeMichele A
Breast Cancer Res Treat; 2023 Apr; 198(2):383-390. PubMed ID: 36689092
[TBL] [Abstract][Full Text] [Related]
4. Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients.
Tjensvoll K; Nordgård O; Skjæveland M; Oltedal S; Janssen EAM; Gilje B
BMC Cancer; 2019 Nov; 19(1):1131. PubMed ID: 31752747
[TBL] [Abstract][Full Text] [Related]
5. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
Ulsemer P; Henderson G; Toutounian K; Löffler A; Schmidt J; Karsten U; Blaut M; Goletz S
Cancer Immunol Immunother; 2013 May; 62(5):875-87. PubMed ID: 23381581
[TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Involvement in Melanoma. Potentials for Detection of Disseminated Tumor Cells and Characterization of Their Subsets by Flow Cytometry.
Chernysheva O; Markina I; Demidov L; Kupryshina N; Chulkova S; Palladina A; Antipova A; Tupitsyn N
Cells; 2019 Jun; 8(6):. PubMed ID: 31234438
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.
Karacosta LG; Fisk JC; Jessee J; Tati S; Turner B; Ghazal D; Ludwig R; Johnson H; Adams J; Sajjad M; Koury S; Roy R; Olson JR; Rittenhouse-Olson K
Transl Oncol; 2018 Apr; 11(2):450-466. PubMed ID: 29477636
[TBL] [Abstract][Full Text] [Related]
8. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
[TBL] [Abstract][Full Text] [Related]
9. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
10. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
[TBL] [Abstract][Full Text] [Related]
11. p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer.
Heublein S; Page SK; Mayr D; Ditsch N; Jeschke U
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1163-70. PubMed ID: 26935926
[TBL] [Abstract][Full Text] [Related]
12. Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.
Schindlbeck C; Andergassen U; Jueckstock J; Rack B; Janni W; Jeschke U
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1883-95. PubMed ID: 26825607
[TBL] [Abstract][Full Text] [Related]
13. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
Kurtenkov O; Klaamas K
Dis Markers; 2015; 2015():761908. PubMed ID: 26663951
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.
Shi L; Xia TS; Wei XL; Zhou W; Xue J; Cheng L; Lou P; Li C; Wang Y; Wei JF; Ding Q
Oncotarget; 2015 May; 6(14):12264-78. PubMed ID: 25881544
[TBL] [Abstract][Full Text] [Related]
15. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.
Pochechueva T; Jacob F; Fedier A; Heinzelmann-Schwarz V
Metabolites; 2012 Nov; 2(4):913-39. PubMed ID: 24957768
[TBL] [Abstract][Full Text] [Related]
17. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
[TBL] [Abstract][Full Text] [Related]
18. Tumour-associated carbohydrate antigens in breast cancer.
Cazet A; Julien S; Bobowski M; Burchell J; Delannoy P
Breast Cancer Res; 2010; 12(3):204. PubMed ID: 20550729
[TBL] [Abstract][Full Text] [Related]
19. Protein modifications as potential biomarkers in breast cancer.
Jin H; Zangar RC
Biomark Insights; 2009 Nov; 4():191-200. PubMed ID: 20072669
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.
Jeschke U; Mylonas I; Kunert-Keil C; Stahn R; Scholz C; Janni W; Kuhn C; Schröder E; Mayr D; Friese K
Histochem Cell Biol; 2009 Feb; 131(2):283-95. PubMed ID: 18853174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
